The Hall-Kaster pivotal disc prosthetic heart valve was introduced in 1977. The primary goal of the design was to obtain the least possible obstruction to flow. Toward this end, innovations in the tilting axis, disc guidance mechanisms, and disc translational freedom combine to improve flow through both orifice segments of the open valve. The present study reports the primary clinical and hemodynamic findings in 28 patients (mean age, 53.8 years) with aortic valve disease, examined 3 months after insertion of the Hall-Kaster pivotal disc valve. The hemodynamics findings displayed low gradients and high calculated orifice areas. Satisfactory flow was observed through both the major and minor openings of the prosthesis. There were no arterial thromboembolic episodes. The increase in serum lactate dehydrogenase activity was moderate, indicating a slight-to-moderate intravascular haemolysis.
THE PRIMARY GOALS of the new Hall-Kaster prosthesis' design were to obtain the least possible obstruction to flow in open position and to increase the size of the small orifice. A new pivotal disc mechanism was designed to split, with the disc in open position, the total valve orifice into two nearly equal parts.
The main components of the valve includes the disc, the valve housing, and the sewing ring ( fig. 1 ). The disc is less than 2 mm in thickness, with an aperture at the center, and is constructed of a graphite substrate containing tantalum to make the disc radiopaque. It is Pyrolite-coated for maximum wear, polishability, and electronegativity. The valve housing is of titanium and includes an annular valve base, a pair of inflow pivots, a single outflow pivot, and an S-shaped disc guidestrut with a disc stop. The disc is fitted to the guidestrut, which controls the movement of the disc throughout its travel. The valve housing with its openended structural members is low in profile and contains no welds or introduced bends. The sewing ring is made of knitted Teflon, and is of conventional construction. In the closed position, the disc is parallel to the plane of the valve base and rests within the orifice on the two inflow pivots and the disc stop. To open, the disc lifts slightly, then pivots about the curved end of the outflow pivot through an arc of 750 in the aortic model. In the open position, the disc is situated near the center of the orifice, dividing the orifice area into two almost equal parts. During the first year of clinical use, two dimensional modifications were made in this valve. First, the clearance between the peripheral edge of the disc and the internal orifice wall was reduced, which in turn reduced the volume of back leakage and theoretically the level of hemolysis. Second, the sewing ring diameter was reduced by 1 mm. This allowed insertion of a valve with a larger internal orifice in a given tissue annulus.
Compared with other available prosthetic valves of the pivotal disc concept, in vitro testing of the Hall-Kaster valve1 has shown improved hemodynamic characteristics. Implantation of the Hall-Kaster valve in the mitral position in dogs2 confirmed its favorable hemodynamic properties, including a low-transvalvular gradient and good diastolic flow through both the large and small orifice.
The Hall-Kaster prosthesis was first used clinically on June 6, 1977;  during the following 8 months, it was implanted in a total of 30 patients with isolated aortic valvular disease. Of these, two patients died in the early postoperative period due to causes unrelated to valve function. To establish a background for continued use, we decided to restudy the remaining 28 patients after 3 months.
Material and Methods

Clinical Material
This study group was comprised of 13 men and 15 women, with an average age of 53.8 years (range, 17 to 71 years); of these, 50% (14/28) were over 60 years of age. Twenty-three patients had both aortic stenosis and insufficiency; the preoperative aortic valve gradient ranged between 54 and 152 mm Hg. Four patients had pure aortic insufficiency. Malfunction of a Starr-Edwards ball valve necessitated replacement in one patient. All patients with one exception were in sinus rhythm. Three were in functional Class I (New York Heart Association criteria) and underwent operation because of recurrent endocarditis, nine were in Class II, 12 monary bypass was instituted using hemodilution and a Rygg-Kyvsgaard bubble oxygenator. After local myocardial cooling, the valve was anchored with interrupted sutures and generally oriented with the large opening anteriorly to the right. The range and number of valve sizes used are listed in table 1. Routine antibiotic treatment with amphicillin and cloxacillin was maintained throughout the first 18 postoperative hours, at which time most patients could be extubated. Anticoagulant therapy with warfarin was begun on the first postoperative day.
Follow-Up Studies
Reexamination took place 3 months after operation, with the exception of one patient restudied after 6 months. During the observation period, the patients were maintained on anticoagulant therapy with warfarin. Most were on maintenance treatment with digitoxin and diuretics. None received iron supplements.
Radiological heart volume was determined in the supine position. Retrograde catheterization of the aortic root was performed in the same way as cise test was carried out in 12 otherwise unselected patients by having them lift the upper part of the body to 60°20 times. The average response to this work was increase in the cardiac output of about 12%. The systolic peak gradient across the valve prosthesis was taken as the difference between peak systolic pressure in left ventricle and aorta. The systolic mean gradient across the prosthesis was determined by planimetric integration of simultaneously recorded left ventricular and aortic pressure, based on at least 3 to 5 representative beats. Effective prosthetic valve areas were calculated from the mean pressure gradient and cardiac output using Gorlin's formula.4 All hemodynamic studies were carried out in the supine position in a mildly sedated state. All pressure were referenced to zero at the fourth intercostal space in the anterior axillary line. Cine recordings (35 mm at 50 frames/sec) and 100 x 100 mm cut film (6 films/sec) were obtained in selected projections to study the movement and function of the valve prosthesis, both with and without contrast medium injections (Isopaque Coronar). Use of specially designed equipment for the evaluation of heart disease, a Kardoscop U (Siemens, Germany), usually made it possible to profile the valve ring and the disc. Thus, the maximum angle of the disc could be easily measured. In this position paravalvular leakage or regurgitation was detectable and could be assessed.
To assess hemolysis, the following laboratory tests were performed: hemoglobin concentration, redblood-cell count, serum bilirubin, serum iron and total iron binding capacity, haptoglobin, serum lactate dehydrogenase (SLDH) (Kabi's reagents), serum aspartate aminotransferase (ASAT), and serum alanine aminotransferase (ALAT).
Statistical Analysis
Statistical analysis was performed using the Student's t test for paired data. All results are expressed as means + SD; p values higher than 0.05 were considered not statistically significant.
Clinical Status
Results
None of the patients demonstrated symptoms of heart failure. Distinct valve sounds were heard at auscultation of the heart. About one-half of the patients had a systolic ejection murmur Grade I-It, and four had a faint diastolic murmur audible along 1-56 the sternal border. Classification of functional capacity according to New York Heart Association criteria3 demonstrated an improvement of one class or more in 75% of the patients (fig. 2 ); 17 were found to be in Class 1, the remaining in Class II. No patients deteriorated. There were no arterial thromboembolic episodes. All but one patient were in sinus rhythm as before operation. Heart Volume Figure 3 demonstrates the changes in heart volume in 27 patients in whom both pre-and postoperative measurements were available. The mean heart volume was reduced from 513 (± 109.7) to 449 (± 93.1) ml/m2 body surface area (t = 5.098, p < 0.001). Ten patients had no definite change in heart size (± 10%). Decreases of more than 20% of the preoperative value were observed in five patients. All but two patients had normal heart volume (less than 550 ml/m2 body surface area) at the time of the restudy.
Cine Recordings and Angiography
The maximal disc opening angle was measured to be from 70°to 750, with a mean value of 73.80. Figure In one case, the disc showed a somewhat trembling movement after reaching maximal opening angle, probably due to extrasystoles. Good systolic flow through the open valve prosthesis was observed to take place both through the major and minor orifice ( fig. 5 left) , giving a normal appearance to the flow in the ascending aorta. In all cases, a minor backflow through the valve prosthesis was observed ( fig. 5 right) . Only one case of paravalve leakage was observed. No thrombus formation on the prosthesis was seen in any case.
Central Hemodynamics
In nine patients in whom pre-and postoperative values were available, cardiac output was essentially unchanged; 6.0 + 1.41 vs 6.0 ± 1. reduced from a mean value of 20.9 ± 10.8 to 10.0 ± 5.2 mm Hg (t = 4.991, p < 0.001). At the restudy, normal values (s 12 mm Hg) were found in about 75% of the patients examined ( fig. 6 ).
Prosthetic Valve Gradient
Systolic peak-to-peak gradient varied from 0 to 20 mm Hg and averaged 7.3 mm Hg, while the systolic mean gradient varied from 6 to 34 Hg and averaged 18.5 mm Hg. Most patients had a mean gradient higher than the peak-to-peak gradient ( fig. 7) . A low peak gradient was found in four patients with a size 26 valve as well as in patients with the modified valve, even in those with the small valve sizes.
The calculated valve area varied-from 1.09 cm2 to 3.52 cm2; figure 8 summarizes the results. We note that the distribution of the effective areas is almost the same in the different valve sizes studied. The patient with a size 23 or 25 close-tolerance model of the valve tended to have higher values for calculated valve area compared to patients with the equivalent valve sizes in the initial model.
Twelve patients were exercised in connection with the recatheterization study. They either demonstrated no change or only a small increase in the prosthetic valve gradient ( fig. 9 ). On an average, the peak gradient increased from 4.8 mm Hg at rest to 10.2 mm Hg during exercise, while the mean gradient increased from an average of 17.8 mm Hg at rest to 23.1 mm Hg. The exercise test was associated with a concomitant rise in cardiac output from a mean value of 6.2 1/min to 7.7 1/min, without significant elevations in left ventricular end-diastolic pressure. Calculated valve area during exercise was slightly higher than at rest 
Discussion
Our present study demonstrates that in the aortic position the disc opening angle of the Hall-Kaster valvular prosthesis in all cases approximated its maximum design capabilities. This differs from our ex-periences with the Lillehei-Kaster valve prosthesis,5 6 which rarely tended to reach its maximum opening angle. The attained opening angle of the Hall-Kaster valve was larger and displayed good blood flow through both the major and minor orifice of the prosthesis. This fact may be of importance in preventing thrombus formation. None occurred during the observation period. The Hall-Kaster aortic prosthesis showed a minor regurgitation to the left ventricle during diastole.
Replacement of the diseased aortic valve with the Hall-Kaster pivotal disc prosthesis resulted in a striking symptomatic improvement. The beneficial effect of the operation was also demonstrated by more objective means.
Our results show that heart volume tended to decrease in most patients after the operation. Significant reduction of cardiomegaly has previously been reported following replacement with the caged-ball valve prosthesis7' 8 as well as after replacement with the Bjork-Shiley9 l`a nd Lillehei-Kaster'0 "' aortic prosthesis. The normalization of the heart volume in our study seems to be at least as good as with the other types of valves.
The left ventricular end-diastolic pressure (LVEDP) was significantly reduced, but did not return to normal levels in all cases. This filling pressure, which is related to changes in the elastic and restrictive properties of the myocardium secondary to long-standing aortic valve disease, usually decreases after valve replacement, but the average values remain in most studies in the high normal range at rest. 9 11, 12 Cardiac output and stroke volume were essentially unchanged after operation and in most cases varied within the normal range. The pulmonary circulation before surgery was characterized by normal pressures in most cases. A normalization in preoperative pulmonary hypertension was seen in a few patients, resulting from a simultaneous decrease in left ventricular filling pressure and pulmonary vascular resistance. The findings in the present study seem to be similar to other studies in this field.7 9 " Direct comparison of the gradients obtained with the Hall-Kaster valve with those of other valves is difficult, since the various series presented in the literature may not have been obtained from patients with a comparable hemodynamic background. Nevertheless, results from studies of patients with aortic Bjork-Shiley and Lillehei-Kaster valves carried out in this hospital" with the same apparatus may provide the best perspective against which the data of the present study can be evaluated. In table 2 we have made a comparison between the gradients, and in table 3 between the effective valve areas (Gorlin) from the present study and from corresponding data utilizing the Bjork-Shiley and the Lillehei-Kaster prosthesis of comparable size (tissue annulus diameter). It is apparent that the Hall-Kaster prostheses tend to have smaller gradients and larger effective areas than the two other pivotal models. Particularly in the small aortic annulus, the Hall-Kaster valve has the more favorable flow characteristics.
It is noteworthy that in our present study the aortic gradients were not consistently elevated during exercise and, in fact, became lower in some patients despite elevations in cardiac output. This finding, previously noted in patients with aortic valvular stenosis13 and with an isolated aortic prosthesis,'14 can probably be best explained by the increase in total blood ejection per minute that accompanies the increased heart rate of exercise. Chronic intravascular hemolysis is a well-known complication of aortic valve replacement and is probably related to the mechanical designs of the prosthesis itself." The elevation of SLDH correlates well with the shortening of erythrocyte survival time. '6 In our patients the average SLDH was slightly raised, but all patients with one exception had less than 1.000 U/1. This means a normal or only moderately reduced life-span of erythrocytes in the great majority of patients examined.'6 The serum haptoglobin was usually absent or much reduced, but is often considered too sensitive a parameter to be used as a reliable index for intravascular hemolysis. The present hematologic study was also carried out at a relatively short postoperative time interval. Investigators with a longer observation period of patients with other types of prosthesis have reported a regression of hemolysis due to endotheliazation of the valve structures.'7 18 If this interpretation is correct, it is reasonable to expect that, with time, one would observe a lesser degree of erythrocyte destruction with the Hall-Kaster prosthesis than indicated by the data presented here. enormous achievement; its low incidence of prosthesis-related complications coupled with an excellent record of durability has made it the first biological prosthesis widely used in the United States.2`5 Its hemodynamic performance has often been unsatisfactory, however, particularly at the high cardiac output of exertion." [6] [7] [8] Other bioprostheses have been produced that attempt to improve on the hemodynamic performance of the Hancock valve while maintaining its other advantages.9
The purpose of our present study was to compare the performance of the four biologic valves (Hancock, Ionescu-Shiley, Carpentier-Edwards, and Angell-Shiley) currently available in the United States. These were evaluated for hydrodynamic performance during forward flow, at relatively large flow rates, and low and high pulse rates in the "'mitral" position in a pulse duplicator built in our laboratory.'0 We also investigated the appropriateness and accuracy of 1-62
